AI assistant
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2024
Aug 22, 2024
31542_dirs_2024-08-22_083bb312-f9d5-4f2f-9af4-63f98d5c880b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-08-20
Reporting Person: Miller Steve (Chief Op. & Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-20 | Common stock, par value $0.001 per share | S | 50000 | $20.261 | Disposed | 775124 | Direct |
| 2024-08-20 | Common stock, par value $0.001 per share | S | 50000 | $20.212 | Disposed | 725124 | Direct |
| 2024-08-20 | Common stock, par value $0.001 per share | S | 50000 | $20.585 | Disposed | 675124 | Direct |
Footnotes
F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2: Shares were sold in various lots from $20.12 to $20.525 per share. The price listed represents a weighted average price for the shares sold.
F3: Shares were sold in various lots from $20.12 to $20.49 per share. The price listed represents a weighted average price for the shares sold.
F4: Shares were sold in various lots from $20.325 to $20.71 per share. The price listed represents a weighted average price for the shares sold.